Details for Patent: 5,258,510
✉ Email this page to a colleague
Drugs Protected by US Patent 5,258,510
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,258,510
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0450097 | ⤷ Subscribe | CA 2009 00031 | Denmark | ⤷ Subscribe |
European Patent Office | 0450097 | ⤷ Subscribe | SPC/GB09/037 | United Kingdom | ⤷ Subscribe |
European Patent Office | 0450097 | ⤷ Subscribe | 300408 | Netherlands | ⤷ Subscribe |
European Patent Office | 0450097 | ⤷ Subscribe | 09C0049 | France | ⤷ Subscribe |
European Patent Office | 0450097 | ⤷ Subscribe | C300408 | Netherlands | ⤷ Subscribe |
Australia | 630284 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |